TORRENT PHARMACEUTICALS LTD. - 500420 - Shareholding for the Period Ended December 31, 2020
Torrent Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here TORRENT PHARMACEUTICALS LTD. - 500420 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mahesh AgrawalDesignation :- Company Secretary and Compliance Officer TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Directorate
As per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we hereby inform that Dr. Chaitanya Dutt (DIN: 00110312), has completed his tenure as Whole-time Director designated as Director (Research and Development) of the Company and also stepped down as the Director of the Company with effect from 31st December, 2020. TORRENT PHARMACEUTICALS LTD. - 500420 - Redemption Of Non-Convertible Debentures
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non Convertible Debentures (NCDs) of Rs 166.70 crores (Rupees One Hundred Sixty Six Crores and Seventy Lakhs) out of the total NCDs of Rs 500 crores (Rupees Five Hundred Crores) issued under ISIN: INE685A07074 has been redeemed and repaid by the Company on 29-Dec-20. TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st January, 2021 and will be re-opened 48 hours after the submission of the Financial Results for the Quarter and nine months ended 31st December, 2020 to the Stock Exchanges. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Regarding Issue Of Commercial Papers
Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has issued Commercial Papers ('CPs') for an amount of Rs 100 Crores (Rupees One Hundred Crores Only) on 15th December, 2020. TORRENT PHARMACEUTICALS LTD. - 500420 - Partial Redemption Of Non-Convertible Debentures
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures (NCDs) of Rs 150 crores (Rupees One Hundred Fifty Crores) out of the total NCDs of ` 500 crores (Rupees Five Hundred Crores) issued under ISIN: INE685A07066 and Rs 142.86 crores (Rupees One Hundred Forty Two Crores Eighty Six Lakhs) out of the total NCDs of Rs 1000 crores (Rupees One Thousand Crores) issued under ISIN: INE685A07082 has been redeemed and repaid by the Company on 14-Dec-20. TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating